Services
-
Phase I/IIa
We have an outstanding 20 years safe and compliant track record in early stage clinical trials.
-
Bioequivalence Services
As a major global player in Clinical Research and Bioanalysis, we provide a wide range of services for bioequivalence studies to the pharmaceutical, and biotechnology industries.
-
505(b)(2)-Generic Hybrid
Development of new or different formulations for known drugs is now a very interesting asset in R&D and clinical research. As a global leader in scientific, clinical and bioanalysis research and through key alliances critical to this sector, our team of experts can help you design and conduct your study successfully.
-
Bioanalysis
Our Bioanalytical Services Department strives for scientific excellence, uncompromised quality and unbeatable timelines to meet and exceed client needs. Our wealth of bioanalytic experience has been gained across different matrices, including plasma, serum, whole blood, urine, cerebro-spinal fluid, tissues and faeces.
